Transparency Market Research

Growing Pool of Geriatric Population to Propel Global Blood Brain Barrier Technologies Market

Transparency Market Research Report Added "Blood-Brain Barrier Technologies Market" to its database.


Albany, NY -- (SBWIRE) -- 04/05/2016 -- Transparency Market Research presents a research report about the global blood-brain barrier technologies market. The research report, titled "Blood-Brain Barrier Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020," details market trends and dynamics governing the overall blood-brain barrier technologies market. It also includes SWOT analysis to highlight the strengths, weaknesses, opportunities, and threats impacting the trajectory of the market segments comprising the global blood brain-barrier technologies market.

Furthermore, the researchers have also conducted Porter's five forces analysis to point out the intensity of competitive rivalry, the bargaining power of suppliers, the threat of substitute products or services, the bargaining power of customers, and the threat of new entrants in the overall market. Additionally, the document has been authenticated with expert opinions from market leaders to help the readers take well-informed business decisions.

The major techniques used for solving blood-brain barrier (BBB) problems are BBB disruption, lipidation, craniotomy-based drug delivery, and cationic import peptides. The application of these technologies is seen in the treatment of meningitis, Parkinson's disease, Alzheimer's disease, encephalitis, and multiple sclerosis. The high prevalence of these diseases is expected to drive the global blood-brain barrier technologies market. The growing pool of the geriatric population is also expected to propel this market, as the elderly are more prone to brain diseases than younger demographics.

Geographically, this market is segmented into Asia Pacific, North America, Europe, and Rest of the World. According to the report, North America held a dominant share in the overall blood-brain barrier technologies market in 2013. However, analysts predict that this share is likely to drop by 2020 due to the significant economic development in Asia Pacific and several Eastern European countries. The India and China markets for blood-brain barrier technologies will grow at a considerable pace due to stabilizing economies and increasing expenditure on healthcare.

Get a Sample of this Report:

Some of the important players in the global blood brain barrier technologies market are Cypress Biosciences Inc., Allon Therapeutics, Inc., Genzyme, CeNeRx BioPharma, Inc, Bioasis Technologies Inc., Ablynx NV, Capsulution Pharma AG, International Brain Barriers Society (IBBS), AngioChem Inc., Cognition Pharmaceuticals LLC, Cephalon Inc., Cytos Biotechnology AG, Cellial Technologies, Envivo Pharmaceuticals, Inc., InSightec, Ltd., H Lundbeck A/S, Adenios, Inc., Bristol-Myers Squibb, Dainippon Sumitomo Pharma (DSP) Co, Ltd., Janssen Pharmaceutica NV, BrainCells Inc, In Cerebro, Diamedica Inc., Geron Corporation, ArmaGen Technologies, Inc., Eli Lilly and Company, and Fabre-Kramer Pharmaceuticals, Inc. The research report provides an insight into the competitive landscape of the global blood-brain barrier technologies market. Furthermore, it also offers an assessment of the financial overview, research and development activities, investment outlook, product portfolio, joint ventures, business and marketing strategies, and strategic mergers and acquisitions of these top companies for the coming few years.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453